Copyright © 2005, European Society of Cardiology
Atrial fibrillation-associated minK38G/S polymorphism modulates delayed rectifier current and membrane localization
aDepartment of Medicine and Research Center, Montreal Heart Institute and University of Montreal, 5000 Belanger Street East, Montreal, Quebec, Canada, H1T 1C8
bDepartment of Anesthesiology, Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada
cDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada
* Corresponding author. University of Montreal, Montreal Heart Institute, Department of Medicine, 5000 Belanger Street East, Montreal, Quebec, Canada H1T 1C8. Tel.: +1 514 376 3330; fax: +1 514 376 1355. Email address: stanley.nattel{at}icm-mhi.org
Background: Atrial fibrillation (AF) is a common acquired arrhythmia with multi-factorial pathogenesis. Recently, a single nucleotide polymorphism (SNP, A/G) at position 112 in the KCNE1 gene, resulting in a glycine/serine amino acid substitution at position 38 of the minK peptide, was associated with AF occurrence (AF more frequent with minK38G); however, the functional effect of this SNP is unknown.
Methods and Results: We used patch clamp recording, confocal microscopy and protein biochemistry to study the effect of this SNP on delayed-rectifier current expression and mathematical simulation to identify potential functional consequences. The density of slow delayed rectifier current (IKs) resulting from co-expression with KvLQT1 was smaller with minK38G (e.g. at +10 mV: 50 ± 7 pA/pF in Chinese hamster ovary (CHO) cells, 45 ± 14 pA/pF for COS-7 cells) compared to minK38S (93 ± 17 pA/pF, 104 ± 23 pA/pF, respectively, P<0.05 for each). IKs kinetics and voltage-dependence were unaffected. Currents resulting from co-expression of human ether-a-go-go-related gene (HERG) were similar for minK38G and minK38S, e.g. upon repolarization from +10 to –50 mV: tail currents 23 ± 4 pA/pF versus 22 ± 5 pA/pF (P = ns). KvLQT1 membrane immunofluorescence was less in CHO cells co-expressing minK38G versus minK38S, and surface expression of KvLQT1, as determined by labelling with streptavidin/biotin, was increased with minK38S co-expression. Computer simulations with a human atrial action potential model predicted that the minK38G SNP would slightly prolong the atrial action potential and reduce the frequency for alternans behaviour. In the presence of reduced repolarization reserve, these effects were enhanced and under specific conditions early afterdepolarizations occurred.
Conclusions: The minK38G isoform is associated with reduced IKs, likely due to decreased KvLQT1 membrane expression. This study reveals a novel amino acid determinant of the minK-KvLQT1 interaction, and if the role of minK38G in AF is confirmed, would suggest mechanistic heterogeneity in genetic determinants of AF.
KEYWORDS Arrhythmia (mechanisms); Gene polymorphisms; Ion channels; K-channel; Repolarization
1 Both authors contributed equally to this work.
Time for primary review 38 days
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
O. Campuzano and R. Brugada Genetics of familial atrial fibrillation Europace, October 1, 2009; 11(10): 1267 - 1271. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Marcus, E. Keung, and M. M. Scheinman The year in review of clinical cardiac electrophysiology. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 777 - 787. [Full Text] [PDF] |
||||
![]() |
D. P. McEwen and J. R. Martens Antifibrillatory Agents and Potassium Channels in the Atria: Pore Block versus Channel Trafficking Mol. Interv., April 1, 2009; 9(2): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nattel Calcium-activated potassium current: a novel ion channel candidate in atrial fibrillation J. Physiol., April 1, 2009; 587(7): 1385 - 1386. [Full Text] [PDF] |
||||
![]() |
N. Li, V. Timofeyev, D. Tuteja, D. Xu, L. Lu, Q. Zhang, Z. Zhang, A. Singapuri, T. R. Albert, A. V. Rajagopal, et al. Ablation of a Ca2+-activated K+ channel (SK2 channel) results in action potential prolongation in atrial myocytes and atrial fibrillation J. Physiol., March 1, 2009; 587(5): 1087 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Husser, M. Stridh, L. Sornmo, D. M. Roden, D. Darbar, and A. Bollmann A Genotype-Dependent Intermediate ECG Phenotype in Patients With Persistent Lone Atrial Fibrillation: Genotype ECG-Phenotype Correlation in Atrial Fibrillation Circ Arrhythm Electrophysiol, February 1, 2009; 2(1): 24 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. Tsai, L.-P. Lai, J.-J. Hwang, J.-L. Lin, and F.-T. Chiang Molecular Genetics of Atrial Fibrillation J. Am. Coll. Cardiol., July 22, 2008; 52(4): 241 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation Circulation, April 15, 2008; 117(15): 1927 - 1935. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Sinner, A. Pfeufer, M. Akyol, B.-M. Beckmann, M. Hinterseer, A. Wacker, S. Perz, W. Sauter, T. Illig, M. Nabauer, et al. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG) Eur. Heart J., April 1, 2008; 29(7): 907 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Lehnart, M. J. Ackerman, D. W. Benson Jr, R. Brugada, C. E. Clancy, J. K. Donahue, A. L. George Jr, A. O. Grant, S. C. Groft, C. T. January, et al. Inherited Arrhythmias: A National Heart, Lung, and Blood Institute and Office of Rare Diseases Workshop Consensus Report About the Diagnosis, Phenotyping, Molecular Mechanisms, and Therapeutic Approaches for Primary Cardiomyopathies of Gene Mutations Affecting Ion Channel Function Circulation, November 13, 2007; 116(20): 2325 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fatkin, R. Otway, and J. I. Vandenberg Genes and Atrial Fibrillation: A New Look at an Old Problem Circulation, August 14, 2007; 116(7): 782 - 792. [Full Text] [PDF] |
||||
![]() |
T. M. Olson, A. E. Alekseev, X. K. Liu, S. Park, L. V. Zingman, M. Bienengraeber, S. Sattiraju, J. D. Ballew, A. Jahangir, and A. Terzic Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes human atrial fibrillation Hum. Mol. Genet., July 15, 2006; 15(14): 2185 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Fatini, E. Sticchi, M. Genuardi, F. Sofi, F. Gensini, A. M. Gori, M. Lenti, A. Michelucci, R. Abbate, and G. F. Gensini Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation Eur. Heart J., July 2, 2006; 27(14): 1712 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dobrev and U. Ravens Do genetics help to better understand the underlying mechanisms of atrial fibrillation? Eur. Heart J., July 2, 2006; 27(14): 1640 - 1641. [Full Text] [PDF] |
||||
![]() |
C. R. Bezzina, A. A.M. Wilde, and D. M. Roden The molecular genetics of arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 343 - 346. [Full Text] [PDF] |
||||








